Inventor · disambiguated record
Steven M. Larson
Also filed as: LARSON STEVEN · LARSON STEVEN M
19 granted patents·18 pending applications·502 citations·filing 1984–2024
94Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER18SLOAN KETTERING INST CANCER RES11SLOAN KETTERING INST CANCER2US HEALTH2BRADBURY MICHELLE1
Top patents by PatentIndex Score
37 records- 0195US6451995B1Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methodsSLOAN KETTERING INST CANCER·Filed 1997·Granted Sep 17, 2002·335 cites·8 claims
- 0294US10548998B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Feb 4, 2020·19 cites·36 claims
- 0393US11419955B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2019·Granted Aug 23, 2022·5 cites·17 claims
- 0493US10167285B2Small-molecule HSP90 inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jan 1, 2019·6 cites·13 claims
- 0593US10039847B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Aug 7, 2018·15 cites·16 claims
- 0692US10548997B2Fluorescent silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Feb 4, 2020·14 cites·13 claims
- 0792US9999694B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2014·Granted Jun 19, 2018·19 cites·48 claims
- 0888US10676476B2Small-molecule HSP90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Jun 9, 2020·3 cites·6 claims
- 0986US9625456B2Fluorescent silica-based nanoparticlesBRADBURY MICHELLE·Filed 2010·Granted Apr 18, 2017·25 cites·13 claims
- 1083US10988534B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 27, 2021·2 cites·16 claims
- 1182US11607465B2Uses of labeled HSP90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2020·Granted Mar 21, 2023·1 cites·8 claims
- 1278US11565005B2Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 31, 2023·1 cites·23 claims
- 1378US4775759ASynthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)US HEALTH·Filed 1984·Granted Oct 4, 1988·46 cites·4 claims
- 1477US11633502B2Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Apr 25, 2023·1 cites·34 claims
- 1577US2024058482A1Uses of labeled hsp90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2023·Application pending·0 cites
- 1675US2025345466A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1772US12161734B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2022·Granted Dec 10, 2024·0 cites·17 claims
- 1871US2021323965A1Small-molecule hsp90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2021·Application pending·0 cites
- 1969US11858993B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jan 2, 2024·0 cites·3 claims
- 2069US2024066144A1Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 2168US2020385389A1Small-molecule hsp90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2020·Application pending·0 cites
- 2260US12195554B2Anti-polysialic acid antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jan 14, 2025·0 cites·20 claims
- 2359US2011300073A118f-labelled three-and four-carbon acids for pet imagingPILLARSETTY NAGAVARAKISHORE·Filed 2009·Application pending·0 cites
- 2456US2023374150A1Anti-psma antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2552US2022348686A1Anti-steap1 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 2651US2025090865A1Lesional dosimetry for targeted radiotherapy of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2751US2003147808A1Single Chain Fv constructs of anti-ganglioside GD2 antibodiesFiled 2002·Application pending·0 cites
- 2851US2022023450A1Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2951US2023346988A1Systems for in vivo monitoring of immune cells in patients undergoing cellular immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3051US2024026037A1Anti-gpa33 multi-specific antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3150US2023256121A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3250US2023348853A1C825 expressing immune cells and diagnostic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3350US2014205543A1Method for diagnosing or treating tumors using sphingomyelin containing liposomesSLOAN KETTERING INST CANCER·Filed 2014·Application pending·0 cites
- 3449US2021017295A1Bispecific binding agents and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 3536US5185142AAntigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapyUS HEALTH·Filed 1989·Granted Feb 9, 1993·10 cites·7 claims
- 3633US10806808B2Systems and methods for determining optimum patient-specific antibody dose for tumor targetingMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Oct 20, 2020·0 cites·53 claims
- 3731US2010226853A1Fluorine-18 derivatives of dasatinib and uses thereofVEACH DARREN R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven M. Larson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →